Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study

Mika A. Sovak,Martee L. Hensley,Jakob Dupont,Nicole Ishill,Kaled M. Alektiar,Nadeem Abu-Rustum,Richard Barakat,Dennis S. Chi,Paul Sabbatini,David R. Spriggs,Carol Aghajanian

Gynecologic Oncology（2006）

引用 84|浏览16

暂无评分

摘要

Conclusion. TC is a well tolerated, active regimen in the treatment of resected, high-risk stage III and IV endometrial cancer that warrants further investigation.

查看译文

关键词

Endometrial cancer,Adjuvant therapy,Carboplatin,Paclitaxel,Retrospective study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要